SAFE Sunscreen Standards Act

Allows the FDA to use real‑world evidence and non‑animal testing methods when evaluating active ingredients in over‑the‑counter (nonprescription) topical drugs, including sunscreens, and requires the agency to publish draft guidance on nonclinical alternatives within one year. It sets minimum content for final administrative orders about nonprescription sunscreen ingredients (including reliance on past safety data and recognition of broad‑spectrum SPF 15+ sun protection) and requires regular public reports to Congress and posting on the FDA website about implementation and progress on non‑animal testing for sunscreens.